Sean Van Helden

3 weeks ago | contagionlive.com | John Parkinson |Sean Van Helden

In a new study presented at MAD-ID, omadacycline was found to have an 86% clinical success rate across a wide-range of infections and pathogens in an immunocompromised population. “This is an effective antibiotic, particularly in this patient population,” study investigator Sean Van Helden, PharmD, Postdoctoral Infectious Diseases Pharmacotherapy fellow, Wayne State University, said.